Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
When some says in 2014 that a partnership is due in the coming year that clearly can mean anytime in 2015! CREDIBILITY IS AN ISSUE...BUT IT IS NOT KINGS!
Not true at all! First of all SK stated in the "upcoming year" not "coming year". Secondly, it is unbelievable that people have to interpret what a CEO means in his public prepared statements. How is an analyst supposed to recommend a company to major investors when he can't understand what a CEO clearly means? Ditto that to major investors and institutions. Obviously the share price agrees! Now only 8 cents away from 52 week low while most of the catalysts are checked off. All of course the most important one - a partnership that has been talked about since 2003. I also agree that in addition to SK's words lacking credibility so does the a make up of the supposedly "independent" penny stock BOD.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 20, 2015. CREDIBILITY IS AN ISUUE. ALL IMO.
Exciting days indeed! After another catalyst inflection point we are now only 9 cents away from 52 week low. This is despited SK being so confident that we will reach our astronomical values. Looks like the street can't wait to buy after another exciting poster presentation.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 20, 2015. CREDIBILITY IS AN ISUUE.
By Request: For the newbies so they have all the information:
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 17, 2015. CREDIBILITY IS AN ISUUE.
PPHM THE COMPANY WHO PLANNED TO PRESENT HCV DATA AT A MAJOR CONFERENCE IN 2012. NOW JANUARY 17, 2015.
PPHM THE COMPANY WHOSE CEO HOPED TO HAVE A COMMERCIAL PRODUCT BY MID JUNE 2012. NOW JANUARY 17, 2015.
PPHM THE COMPANY WHOSE CEO WANTED A PARTNER BEFORE PHASE III PROTOCOL FOR BAVI AND COTARA. NO PARTER AS OF JANUARY 17, 2015.
PPHM THE COMPANY THAT ANNOUNCED IT HAD A SHANGHAI SUBSIDIARY IN 2007. HASN'T BEEN HEARD FROM SINCE.
PPHM THE COMPANY WHOSE TOP EXECUTIVES, ZEISBALL, LYTLE AND SHAN TO NAME A FEW DO NOT PARTICIPATE IN THE COMPANY DISCOUNT STOCK PURCHASE PLAN EVEN THOUGH THEY MAY KNOW HOW VALUABLE THE COMAPNY IS.
PPHM THE COMPANY WHOSE COB CARLTON JOHNSON VOWED TO GET TO THE BOTTOM OF THE BOTCHED TRIAL. NOW JANUARY 17, 2015. WITH NO RESOLUTION.
PPHM THE COMPANY THAT IS A 10 YEAR DOWNTREND WITH STOCK DOWN ROUGHLY 75% OVER THAT TIME AND MORE THAN 50% SINCE REVERSE SPLIT IN 2009.
PPHM THE COMPANY WHOSE CEO STATED IN 2009 THAT THEY WERE LOOKING FOR QUALIFIED CANDIDATES TO ADD TO THE BOARD IN RESPONSE TO CARLTON JOHNSON'S APPOINTMENT AS COB. AS OF JANUARY 17, 2015. NO ADDITIONS TO BOARD.
PPHM THE COMPANY WITH NO EARNINGS AND $260M MARKET CAP WHOSE BOD MEMBERS EARN MORE THE MAJORITY OF MULTI-BILLION DOLLAR, INTERNATIONAL FORTUNE 500 CAMPANIES
PPHM, THE COMPANY THAT ENTERED INTO A $50M PARTNERSHIP DEAL WITH DIOS, A COMPANY THAT DOESN'T EXIST
PPHM THE COMPANY THAT... well... read it for yourself:
TWST: Can you give us a realistic picture as to where you see Peregrine in the year 2005?
Mr. King: I see the company as hopefully having partnered Cotara to move that program forward. By then, I would hope that we could be nearing the completion of the Phase III clinical trial. The timing of that will be dependent on the partner. I view the company as really focusing its efforts on vascular targeting and the Vasopermeation Enhancement Agent programs. I view us as having strong clinical programs in both of those areas.
Biotechnology >> CEO Interview >> July 28, 2003
http://www.twst.com/interview/16148
What year is it now?
Please feel free to add to the list as I am sure they are numerous things left out. ALL IMO.
Cross off another potential catalyst from the newbie list as a non event. Only thing that matters now is money and credibility which is something that the BOD lacks.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 16, 2015. CREDIBILITY IS AN ISUUE.All IMO.
Great Post Realist about the dilution. Keep in mind that during this great dilution period mgmt at any time could have increased the amount of financing they were receiving by just appointing a qualified CEO, a qualified CFO, a qualified COB and or addtional board members. The fact they continue to not do so to this day speaks value of this penny stock BOD and company. Keep in mind also that SK and the board have publicly stated they have been looking for addtional board members since 2010. I guess they can't find other penny stock people and or perhaps respectable people do not want to be associated with PPHM and the Board. The $1.40 stock price speaks for itself.
As for the ridiculous alleged statement from CK that partners want more data (may rank up there with IR's response that company was pulling out of conference for personal family reasons), where is the data supposed to come from? I thought it was implied that the data already on hand is actually better than the reconstructed data? If they are waiting on Sunrise data then they are indeed going alone and are STUPID.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 15, 2015. CREDIBILITY IS AN ISUUE.All IMO.
Not hammering on Cotara. I am hammering on the statement that it was commonly known that it would take 10 to 15 years for something to come from the pipeline at that point in time.
That statement is false! Mgmt was figuring on running a phase III trial in 2003 and partnering therefore they expected to have something in the pipeline!
In any event we are once again only 13 cents from 52 week lows during our current 10 year plus downtrend.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 15, 2015. CREDIBILITY IS AN ISUUE.All IMO.
It wasn't me that said that. Cramer said it in Oakland or at least somewhere in California. I was in so many places at the time that I can't tell exactly. I wouldn't even have know about TCLN/PPHM without that.
Well this statement sure reads like you said it(very least agree with it) and that Cramer agreed.
Back then it was commonly known that TCLN/PPHM was on for 10 to 15 years before anything would come out of the pipeline. Even Cramer proclaimed that at the time.
No matter who said it, it simply isn't true since a P3 protocol for COTARA was approved in 2003 and mgmt was looking for a partner and supposedly still are.
PPHM THE COMPANY WHO OPENED A CHINA SUBSIDIARY IN 2007 AND HASN'T BEEN HEARD FROM SINCE. ALL IMO.
You stated the following:
Back then it was commonly known that TCLN/PPHM was on for 10 to 15 years before anything would come out of the pipeline. Even Cramer proclaimed that at the time.
Well that is simply not true. How could it be possible known that nothing would come in 10 to 15 years when in 2003 the phase III protocol was approved and even mgmt stated they would be partnering?
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 15, 2015. CREDIBILITY IS AN ISUUE.All IMO.
Back then it was commonly known that TCLN/PPHM was on for 10 to 15 years before anything would come out of the pipeline. Even Cramer proclaimed that at the time.
Huh? Cotara Phase 3 protocol was approved in 2003 and they stated that that they hoped to partner for Cotara SOON?
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 15, 2015. CREDIBILITY IS AN ISUUE.
By Request: For the newbies so they have all the information:
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 10, 2015. CREDIBILITY IS AN ISUUE.
PPHM THE COMPANY WHO PLANNED TO PRESENT HCV DATA AT A MAJOR CONFERENCE IN 2012. NOW JANUARY 10, 2015.
PPHM THE COMPANY WHOSE CEO HOPED TO HAVE A COMMERCIAL PRODUCT BY MID JUNE 2012. NOW JANUARY 10, 2015.
PPHM THE COMPANY WHOSE CEO WANTED A PARTNER BEFORE PHASE III PROTOCOL FOR BAVI AND COTARA. NO PARTER AS OF JANUARY 10, 2015
PPHM THE COMPANY THAT ANNOUNCED IT HAD A SHANGHAI SUBSIDIARY IN 2007. HASN'T BEEN HEARD FROM SINCE.
PPHM THE COMPANY WHOSE TOP EXECUTIVES, ZEISBALL, LYTLE AND SHAN TO NAME A FEW DO NOT PARTICIPATE IN THE COMPANY DISCOUNT STOCK PURCHASE PLAN EVEN THOUGH THEY MAY KNOW HOW VALUABLE THE COMAPNY IS.
PPHM THE COMPANY WHOSE COB CARLTON JOHNSON VOWED TO GET TO THE BOTTOM OF THE BOTCHED TRIAL. NOW JANUARY 10, 2015 WITH NO RESOLUTION.
PPHM THE COMPANY THAT IS A 10 YEAR DOWNTREND WITH STOCK DOWN ROUGHLY 75% OVER THAT TIME AND MORE THAN 50% SINCE REVERSE SPLIT IN 2009.
PPHM THE COMPANY WHOSE CEO STATED IN 2010 THAT THEY WERE LOOKING FOR QUALIFIED CANDIDATES TO ADD TO THE BOARD IN RESPONSE TO CARLTON JOHNSON'S APPOINTMENT AS COB. AS OF JANUARY 10, 2015 NO ADDITIONS TO BOARD.
PPHM THE COMPANY WITH NO EARNINGS AND $260M MARKET CAP WHOSE BOD MEMBERS EARN MORE THE MAJORITY OF MULTI-BILLION DOLLAR, INTERNATIONAL FORTUNE 500 CAMPANIES
PPHM, THE COMPANY THAT ENTERED INTO A $50M PARTNERSHIP DEAL WITH DIOS, A COMPANY THAT DOESN'T EXIST
PPHM THE COMPANY THAT... well... read it for yourself:
TWST: Can you give us a realistic picture as to where you see Peregrine in the year 2005?
Mr. King: I see the company as hopefully having partnered Cotara to move that program forward. By then, I would hope that we could be nearing the completion of the Phase III clinical trial. The timing of that will be dependent on the partner. I view the company as really focusing its efforts on vascular targeting and the Vasopermeation Enhancement Agent programs. I view us as having strong clinical programs in both of those areas.
Biotechnology >> CEO Interview >> July 28, 2003
http://www.twst.com/interview/16148
What year is it now?
Please feel free to add to the list as I am sure they are numerous things left out. ALL IMO.
Read the Bio's of the BOD of Halozyme Therapeutics Avid's largest customer and then read the Bio's of PPHM's BOD. It's kind of embarrassing! IMHO
I believe if you compare the Bio of the BOD from most other companies besides some penny stock BOD's to the Bio's of PPHM BOD its kind of embarrasing. SK has been looking for over four years to add to the BOD yet he has not done so to date.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER. ALL IMO.
They could double the share price with two easy steps. Announce a bio heavyweight has joined the bod, and announce that the PIII is enrolling well with over xxx patients being treated.
SK stated (I Know he says a lot of things) in 2010 at the shareholders meeting that they were looking for candidates to expand the BOD after they laughingly put Carlton Johnson as COB. It has also been eight years since our China Subsidiary opened yet we never hear anything about it. Was this another DIOS? Is today the day they announce the PIPE? It will be SOONER than later.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 09, 2015. CREDIBILITY IS AN ISUUE. ALL IMO.
Not sure it means anything, but it is interesting that PPHM is not participating in the Bio Showcase next week in San Francisco but will be participating in Bio-Europe Spring 2015
Prpobably just means that shareholders will be footing the bill once again for SK and his entourage to fly to Europe and party instead of just heading to San Francisco for practically nothing. Maybe they will head over to China and visit our subsidiary since it has been 8 years and no deals from China yet. Perhaps Mary Boyd is hiding there. Market flying again today yet pphm still only 12 cents from 52 week low. Pipe should be coming SOONER than later.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 08, 2015. CREDIBILITY IS AN ISUUE. ALL IMO.
They should separate the two in my opinion. MAKE IT A WHOLLY OWNED SUBSIDIARY IN THE EVENT WE HAVE POOR RESULTS
Isn't AVID already a wholly owned subsidiary?
We also have a subsidiary in China. I wonder why no updates? Here is the PR for 2007. BTW CJ was also involved in the lawsuit announced in the PR. Needless to say it wasn't a win for shareholders.
January 12, 2007
Peregrine Pharmaceuticals Establishes Wholly Owned Subsidiary in China
- Company Also Files Lawsuit Against Cancer Therapeutics Laboratories, Inc.
Alleging Breach of Contract Regarding Its License to Peregrine's TNT Drug in China -
TUSTIN, Calif., Jan. 12 /PRNewswire/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing targeted therapeutics for the treatment of cancer and hepatitis C virus (HCV) infection, today announced it has established a wholly foreign-owned enterprise (WFOE) in the People's Republic of China. The new subsidiary, Peregrine Beijing Pharmaceuticals Technology Development Ltd., is located in Beijing.
"The Chinese pharmaceutical market is currently the ninth largest in the world and is growing rapidly, doubling in size in the past five years with continued robust expansion expected," said Steven W. King, president and CEO of Peregrine. "China therefore represents an important strategic market opportunity for Peregrine, and our new wholly owned subsidiary will give us the opportunity to leverage our products and technology in this market. China also represents a tremendous resource for drug discovery and development, and we intend to explore all options for the development of our product candidates in China."
Separately, Peregrine announced that it has filed a lawsuit alleging breach of contract against its licensee Cancer Therapeutics Laboratories, Inc. (CTL), a California corporation that has licensed certain rights under the company's Tumor Necrosis Therapy (TNT) technology platform exclusively for development and commercialization in the People's Republic of China.
The lawsuit filed in the Superior Court of the State of California for the County of Orange against CTL alleges various breaches of contract, including failure to provide substantive clinical data to Peregrine from a sublicensing arrangement in China regarding Peregrine's TNT agent, failure to account for a purported current sublicense agreement with a company in China named Shanghai Medipharm Biotech despite repeated attempts by Peregrine to obtain evidence of an agreement, and failure to provide an accounting of any revenue, equity and substantive data derived from that purported sublicense agreement.
"We regret having to resort to a lawsuit, but CTL has not complied with our agreement to provide us with information related to the purported Medipharm sublicense or substantive data on their activities regarding the development and marketing of our TNT agent for lung cancer," said Paul Lytle, chief financial officer of Peregrine. "We therefore intend to vigorously pursue our rights and remedies."
About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing five separate clinical trials in cancer and HCV infection in the U.S. and India with its lead product candidates bavituximab and Cotara®. Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.
Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that the Company may not be able to get approval to initiate clinical trials or conduct any other form of drug development work in China. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the Company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2006, and the quarterly report on Form 10-Q for the quarter ended October 31, 2006. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.
SOURCE Peregrine Pharmaceuticals, Inc.
CONTACT: Investors, GendeLLindheim BioCom Partners, +1-800-987-8256, info@peregrineinc.com, for Peregrine Pharmaceuticals, Inc.; or Media, Barbara Lindheim, +1-212-918-4650, for Peregrine Pharmaceuticals, Inc.
/Web site: http://www.peregrineinc.com /
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 07, 2015. CREDIBILITY IS AN ISUUE. ALL IMO.
SK already knows if Sunrise trial will be successful. IMO, SK is so confident, and is so willing to indulge the go-it-alone scenario, because he already has a pretty good idea of how Phase III Sunrise patients are doing from comparing enrollment numbers with overall number of Bavi doses shipped.
Yes he is so sure that he doesn't even fully participate in his companies discount stock plan where he could have purchase shares at $1.08 and lower. I guess anything is possible.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 06, 2015. CREDIBILITY IS AN ISUUE. ALL IMO.
Wook it up for $1.36. Only 9 cents from 52 week low. No worries though because it must be tax selling season. Oh wait we are already in 2015.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 06, 2015. CREDIBILITY IS AN ISUUE. All IMO.
By Request: Just so newbies actually know the facts as to what has happened in the past.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW January 04, 2015. CREDIBILITY IS AN ISUUE.
PPHM THE COMPANY WHO PLANNED TO PRESENT HCV DATA AT A MAJOR CONFERENCE IN 2012. NOW JANUARY 4, 2015.
PPHM THE COMPANY WHOSE CEO HOPED TO HAVE A COMMERCIAL PRODUCT BY MID JUNE 2012. NOW JANUARY 4, 2015.
PPHM THE COMPANY WHOSE CEO WANTED A PARTNER BEFORE PHASE III PROTOCOL FOR BAVI AND COTARA. NO PARTER AS OF January 4, 2015
PPHM THE COMPANY THAT ANNOUNCED IT HAD A SHANGHAI SUBSIDIARY. HASN'T BEEN HEARD FROM SINCE.
PPHM THE COMPANY WHOSE TOP EXECUTIVES, ZEISBALL, LYTLE AND SHAN TO NAME A FEW DO NOT PARTICIPATE IN THE COMPANY DISCOUNT STOCK PURCHASE PLAN EVEN THOUGH THEY MAY KNOW HOW VALUABLE THE COMAPNY IS.
PPHM THE COMPANY WHOSE COB CARLTON JOHNSON VOWED TO GET TO THE BOTTOM OF THE BOTCHED TRIAL. NOW JANUARY 4, 2015 WITH NO RESOLUTION.
PPHM THE COMPANY WHOSE CEO STATED IN 2009 THAT THEY WERE LOOKING FOR QUALIFIED CANDIDATES TO ADD TO THE BOARD IN RESPONSE TO CARLTON JOHNSON'S APPOINTMENT AS COB. AS OF JANUARY 04, 2015 NO ADDITIONS TO BOARD.
PPHM THE COMPANY THAT IS A 10 YEAR DOWNTREND WITH STOCK DOWN ROUGHLY 75% OVER THAT TIME AND MORE THAN 50% SINCE REVERSE SPLIT IN 2009.
ALSO PAST HISTORY COURTESY OF CORP:
All of the following took place under the current management team and, in my opinion, is why we are at where we are.
The $50 million dollar DIOS deal that was perpetrated on Wall Street by this crew, May, 2007.
ir.peregrineinc.com/releasedetail.cfm?ReleaseID=266038
The reverse split to stay Nasdaq compliant, October, 2009.
http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=416393
The Stason "deal", May 2010.
http://www.biospace.com/news_story.aspx?StoryID=178872
The 80%, one day drop in the pps due to "major discrepancies"
http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=708954
Outstanding shares on September 30, 2009, 45m. Outstanding shares current, 180m. Dilution by a factor of 4 and no end in sight.
Insider ownership, less than one percent.
Chairman of the Board of Directors.
http://ir.peregrineinc.com/directors.cfm
Most of these things are in the past but they all matter. It is how the company is judged. Putting out a pr about bird flu or ebola when they are hot to get a quick, temporary bump in the share price is not viewed in a positive light. Mentioning that you are in partnership talks for over ten years and not having anything to show for it is not good. Switching from King to Worsley in mentioning partners does nothing. King is likely too embarrassed to say it any more. Good for him.
Maybe this post should be a sticky that people can be referred to anytime somebody asks why another company is where it is at in relation to PPHM.
I realize that none of the above matters to many here, but it matters to Wall Street and institutional investors. It is why the pps is what it is and the institutional holdings are what they are. The pps means nothing to many here, that's fine. It does mean something to me. I am currently slightly under water on this stock and I would like to make some money on it. I guess 2017 is our year.
Also, this is the qualifications of our handpicked COB courtesy of Corp.
"The Board of Directors concluded that Mr. Johnson should serve as a director in light of the extensive public company finance experience that he has obtained through serving on the boards and audit committees of Patriot Scientific Corporation, CryoPort, Inc. and Ecotality, Inc."
Patriot Scientific closed Friday at .03.
Ecotality, currently in bankruptcy closed Friday at .001.
Cryport, the crown jewel with a $27m market cap, closed Friday at .45, down from $9.30 in 2010.
That is our leader and those are his qualifications.
Please feel free to add to the list as I am sure they are numerous things left out. ALL IMO.
If Mr. King thought "fruition" would be in 2014 he would have said "THIS YEAR" not the "COMING YEAR"
Mr. King used the word "UPCOMING YEAR". If he wanted to mean 2015 he should have said "NEXT YEAR".
The point is irrelevant. It is a pattern with this mgmt team to have ambiguous statements in their words and in their PR's. You shouldn't have to hypothesis and list 1000 theories on what mgmt meant to stay. That is no way to draw in big investors. Unless of course you don't want to be straightforward for some reason.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 03, 2015. CREDIBILITY IS AN ISUUE. All IMO.
SK did not say the coming or following year he said "upcoming year". Is there a definition for upcoming? If someone says on January 2nd, 2015 in the coming year does that mean he means in 2016? Why not just say next year? The fact that there are still disagreements implies that it is not clear. You are not going to get big time investors, analyst coverage, and institutions investing big money by being vague. Big money wants to know what is going on for sure. Perhaps they do know what is really going on since big money and institutions(other than the family) have not bought in. SK may get the benefit of the doubt if this was the first time. We are still waiting on the HCV data to be presented at a major conference in 2012. Perhaps he would have been better off saying in the coming years.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER. ALL IMO.
however if he meant 2014 why would he not say " this year"
If he meant 2015 why didn't he just say next year or simply in 2015? Just the fact that everyone has different opinions is the biggest problem! regardless of what SK actually meant. The company should be clear and precise what their objectives are!
How can an investment firm make recommendations to clients, investors etc.. if they do not know what the CEO meant?
How can analysts give reports that lead to institutional buying if they don't know what the CEO meant with his statements?
This has been going on for years not only with mgmt.'s statements but with their own PR's which have billions of theories associated with them after they are released. Quite ridiculous to say the least.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 02, 2015. CREDIBILITY IS AN ISUUE. All IMO.
Last year on March 6th 36 million shares were traded from $2.48 to $3.18 yet for some reason Paul Lytle didn't sell loads of ATM shares into it. Perhaps he didn't know that it was going to take a few years to complete the trial or he thought that we wouldn't need the money since he knew SK was going to talk later about a partner coming to fruiton in the upcoming year who knows. It is now January 2nd 2015 and no partner yet. SK also wanted a partner on board before the EOP meetings end of year 2012. Maybe this year will be the year!
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER. ALL IMO.
Our goal for the program is to position ourselves, along with a potential partner, to initiate Ph3 by mid-2013, which means an EOP2 meeting by yr-end'12. It would be ideal to have a partner on board to participate in the EOP2 meeting,
Unfortunately SK words, goals,hopes etc.. have been shown to be worthless to date.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW JANUARY 02, 2015. CREDIBILITY IS AN ISUUE. All IMO.
$1.37 AH. Oh well, lets see if we see the pipe later today or Friday. The good news is we have a lower base for next years gains during our current 10 year downtrend. Happy New Year!
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 31, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
Once again, you shouldn't have to interpet what a CEO means. It should leave no doubt what he is talking or referring about. Its common sense.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 31, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
U forgot to mention, eyebuy, that it could...
mean "fiscal" year. Why is that?
Just the fact that you have to interpert what SK stated for when a partnership is coming is the problem! Why on earth would you have to speculate what a CEO meant when he says something? It is no way to run a company and no way to attract investors. Investors want to know what the plan is and if they can trust mgmt. PPHM mgmt and the BOD are failing in that respect.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 31, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
Wook it up at $1.38. Will pphm close down for the year and 11 cents from 52 week low while market at all time high?
Only couple of hours before our CEO officially stretches the truth again. Not the first time. Still looking for that HCV data that was going to be presented in 2012. Still wouldn't be surprised if pipe is announce today. PIPE has to be coming SOON!
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 31, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
Hey I am just stating what the CEO stated. You can draw your own conclusions. The problem as always with the company is that they do not communicate clearly. There should be no doubt what the CEO states or means to say. It just creates chaos. It is ridiculous that no one knows what the CEO means. If you have nothing to hide or you are not making something up then there is no reason not to be clear on your objectives. It also doesn't hurt to follow up on your statements or objectives. How can you gain credibility when you state you plan to release HCV data at a 2012 conference and not follow up on that statement when we will be going on 2015?
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 31, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
Sorry cheynew but it is past 8am which in all probability means no news. I should qualify and say no good news as there is always after hours.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 31, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
Wook it up baby now $1.38. End of year markdown. What a bargain! Anything under $2, ugh $1.75, ugh $1.50, ugh make that $1.40 is a steal! Pipe coming soon! 12 cents away from 52 week low and still down over 50% from Reverse split and 75% from its 10 year downtrend.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 30, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
Partnership Fruition? Or Merely More Smoke and Mirrors?
With the performance history and shady past of this BOD it is hard to take any thing this BOD states seriously.
This is after all a company that openly states it has an independent board yet one can easily verify that statement is misleading at best.
Looks like the pipe will be announced SOON! Could mgmt announce it today after close or perhaps tomorrow or Friday? Time will tell.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 30, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
$1.48 AH....
$1.43 in real time.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 30, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
Any guesses on how much we drop today?
Does it really matter how low we go? Anything under $5, wait $4, wait $3. wait $2, uhh I mean $1.50 is a bargain!Yeah thats the ticket!
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 24, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
I sure hope nothing has happened to the protector of the cloak. The last we heard was a false statement that Pohl and King had no ties to PTSC. The plot thickens......
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 22, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
i do not understand why the preferred hasn't been sold. would love to know if they've tried...unsuccessfully, or if they have not offered any more than what's been sold. of course, if people want it for the dividend and the conversion, wouldn't the PPHMP price be on the rise if shares weren't available? i guess that answer would tell me everything i'd need to know...
One still has to wonder why Paul Lytle did not sell a boatload of ATM shares in the high $2 range in the 60 million share trading days? Did friends of mgmt not want the shares at that price? Who does the BOD work for?
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 22, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
Maybe someday someone will be correct on the positive side. This was posted last Friday.
Juno up 56% on IPO. Bigger market cap than PPHM
Compare there BOD to PPHM BOD. It is almost embarrassing for pphm.
http://junotherapeutics.com/about-us/board-of-directors/
Wouldn't be surprise to see a pipe financing soon one Friday afternoon. The money has to come from somewhere.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 22, 2014. CREDIBILITY IS AN ISUUE. ALL IMO.
Wow. I guess I called the pipe coming before christmas or just after christmas! This company never fails to amaze. What a joke! Don't worry these are for the family who already owns 97 million shares. Wook it up baby for another buying opportunity. I guess mgmt knows the value of the company and that is why they did not purchase shares at a discount. All imo.
The December rally takes the Dow to an all time high while pphm continues its 10 year downtrend down about 5% for the month of December at $1.40 and 14 cents away from its 52 week low. Even though Sunrise is in about a year the street gives the penny stock BOD mgmt no credibility. Partnership(real one this time) is the only thing that will move the stock.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER. ALL IMO.
Great Post and to the point! Enough with the wild theories and thoughts on what mgmt may be saying or doing. The proof is in their actions which has not produced the promised partner or BOD members. So far shareholders only have a $1.43 stock price.
Dr. Garnick made a fantastic presentation at the ASM about the length of time and the great deal of paperwork to get through the FDA approval hurdle. Even he and Steve King made no reference to stopping the trial earlier. Please refrain from setting false expectations on this board when management has a difficult enough time bringing their stated goals to fruition.
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER. ALL IMO.
Also please don't quote the garbage that comes out of SK's mouth.. If you go through the PR's you would be amazed at what has been said by that guy.
Agreed here are some of the more famous quotes from SK's mouth"
We hope to have a commercial product by mid 2012. (Nothing to date)
We hope to have a partner for Cotara and Bavi before phase III protocol. (No Partner to date)
PPHM tends to flow with the ebb of the market. (Market near all time highs, pphm down over 75% over 10 years, down over 50% since reverse split in 2009 and currently near 52 week low)
We are in TALKS! (Too funny to even talk about)
In March 2014 stated partnership in upcoming year. (Nearing end of 2014)
Slide 28 creating shareholder value. (Negative)
SK stated value is astronomical but doesn't purchase full amount of shares in company discount plan.
Lastly in 2009 he stated they were looking for qualified people to add to the BOD. (Guess it is hard to find people without a conscience either that or everybody else is overqualified)
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER. ALL IMO.
By Request: For the newbies so they have all the information:
PPHM THE COMPANY THAT STATES IT HAS AN INDEPENDENT BOARD YET 75% OF THE COMPANY WHICH INCLUDES ERIC SCWARTZ, DAVID POHL AND CARLTON JOHNSON ALL SERVED ON THE PENNY STOCK COMPANY PTSC AND ALL HAVE TIES TO EACH OTHER.
PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW DECEMBER 19, 2014. CREDIBILITY IS AN ISUUE.
PPHM THE COMPANY WHO PLANNED TO PRESENT HCV DATA AT A MAJOR CONFERENCE IN 2012. NOW DECEMBER 22, 2014.
PPHM THE COMPANY WHOSE CEO HOPED TO HAVE A COMMERCIAL PRODUCT BY MID JUNE 2012. NOW DECEMBER 22 2014.
PPHM THE COMPANY WHOSE CEO WANTED A PARTNER BEFORE PHASE III PROTOCOL FOR BAVI AND COTARA. NO PARTER AS OF DECEMBER 22, 2014
PPHM THE COMPANY THAT ANNOUNCED IT HAD A SHANGHAI SUBSIDIARY. HASN'T BEEN HEARD FROM SINCE.
PPHM THE COMPANY WHOSE TOP EXECUTIVES, ZEISBALL, LYTLE AND SHAN TO NAME A FEW DO NOT PARTICIPATE IN THE COMPANY DISCOUNT STOCK PURCHASE PLAN EVEN THOUGH THEY MAY KNOW HOW VALUABLE THE COMAPNY IS.
PPHM THE COMPANY WHOSE COB CARLTON JOHNSON VOWED TO GET TO THE BOTTOM OF THE BOTCHED TRIAL. NOW DECEMBER 22, 2014 WITH NO RESOLUTION.
PPHM THE COMPANY THAT IS A 10 YEAR DOWNTREND WITH STOCK DOWN ROUGHLY 75% OVER THAT TIME AND MORE THAN 50% SINCE REVERSE SPLIT IN 2009.
PPHM THE COMPANY WHOSE CEO STATED IN 2009 THAT THEY WERE LOOKING FOR QUALIFIED CANDIDATES TO ADD TO THE BOARD IN RESPONSE TO CARLTON JOHNSON'S APPOINTMENT AS COB. AS OF DECEMBER 22, 2014 NO ADDITIONS TO BOARD.
PPHM THE COMPANY WITH NO EARNINGS AND $260M MARKET CAP WHOSE BOD MEMBERS EARN MORE THE MAJORITY OF MULTI-BILLION DOLLAR, INTERNATIONAL FORTUNE 500 CAMPANIES
PPHM, THE COMPANY THAT ENTERED INTO A $50M PARTNERSHIP DEAL WITH DIOS, A COMPANY THAT DOESN'T EXIST
PPHM THE COMPANY THAT... well... read it for yourself:
TWST: Can you give us a realistic picture as to where you see Peregrine in the year 2005?
Mr. King: I see the company as hopefully having partnered Cotara to move that program forward. By then, I would hope that we could be nearing the completion of the Phase III clinical trial. The timing of that will be dependent on the partner. I view the company as really focusing its efforts on vascular targeting and the Vasopermeation Enhancement Agent programs. I view us as having strong clinical programs in both of those areas.
Biotechnology >> CEO Interview >> July 28, 2003
http://www.twst.com/interview/16148
What year is it now?
Please feel free to add to the list as I am sure they are numerous things left out. ALL IMO.